The Tuberculosis Vaccine Initiative (TBVI) and IAVI have recently updated and expanded the TB Vaccine Development Pathway, a methodology and tool that provides a structured development path and [...]
The workshop “Maintaining European scientific excellence and global leadership in TB Vaccine R&D EU funded collaborative research and innovation” organised by three H2020 funded projects [...]
Recently the article ‘Insights and challenges in tuberculosis vaccine development’ by Prof. Helen McShane was published in The Lancet.
The VALIDATE Network has a vacancy for a Postdoctoral Bioinformatician/Computational Biologist, based at the Jenner Institute at Oxford University. VALIDATE is an international network of [...]
Press release: Results from new trial of the candidate TB vaccine MTBVAC offer hope for control of tuberculosis in infants First trial of a new live attenuated Mycobacterium tuberculosis [...]
Runderweg 6
8219 PK Lelystad
The Netherlands
Email: info@tbvi.eu
Phone: +31 320 277 550
